top of page

CHO-K1/Human CRF1 Stable Cell

Item
Cat#
Price

Stable Cell Line

SNB-G-0080A

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)


Product Description


CRF1 receptor (CRHR1), a G protein-coupled receptor, is the primary receptor for corticotropin-releasing hormone. It is widely distributed in brain regions involved in stress and emotional regulation, such as the amygdala, hypothalamus, and cerebral cortex, and also expressed in the anterior pituitary and immune system. As the "master switch" of the body's stress response, its activation initiates the hypothalamic-pituitary-adrenal axis, leading to cortisol release. It directly regulates behaviors like anxiety, depression, learning, and memory. Consequently, CRF1 receptor antagonists represent a major research direction for developing novel therapies for depression, anxiety, and other stress-related psychiatric disorders.

 

Screeningbio’s CHO-K1/Human CRF1 cell line overexpress CRHR1 and is designed to detect increases in intracellular cAMP levels in response to agonist stimulation of the receptor. Cisbio HTRF cAMP kit can be used to detect the signal.

Product Specifications

Target Type

GPCR

Species

Human

HGNC Symbol

CRHR1

Accession Number

NM_004382

Parental Line

CHO-K1

Lot#

See Vial

Storage

Liquid Nitrogen


Data


CHO-K1/Human CRF1 Agonist Assay. CHO-K1/Human CRF1 cells were treated with the reference agonist. The assay was run based on Revvity cAMP HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.
CHO-K1/Human CRF1 Agonist Assay. CHO-K1/Human CRF1 cells were treated with the reference agonist. The assay was run based on Revvity cAMP HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.


Target Background


CRF1 receptor (CRHR1), a G protein-coupled receptor, is the primary receptor for corticotropin-releasing hormone. It is widely distributed in brain regions involved in stress and emotional regulation, such as the amygdala, hypothalamus, and cerebral cortex, and also expressed in the anterior pituitary and immune system.


As the "master switch" of the body's stress response, its activation initiates the hypothalamic-pituitary-adrenal axis, leading to cortisol release. It directly regulates behaviors like anxiety, depression, learning, and memory. Consequently, CRF1 receptor antagonists represent a major research direction for developing novel therapies for depression, anxiety, and other stress-related psychiatric disorders.




Product Documentation



bottom of page